Exchange: NYSEMkt·Updated 07:45 PM EST
AEON logo

AEON AEON Biopharma Inc. - Ordinary Shares - Class A

$0.123
$0.0101
(7.59%)
Today
Closed $0.123
$0.001
(0.81%)
After Hours
Mkt Cap$10.35M
Vol1.17M

About AEON

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
76

Extremely Bullish Sentiment

How do you feel about AEON?

adaptnow
$AEON As of November 16, 2026, the Company had received approximately $6.2 million in gross proceeds from exercises of these warrants, providing additional capital to support the continued advancement of the ABP-450 development program. Any warrants remaining unexercised will expire on November 16, 2026.
1
Golfskier
$AEON Well, if shareholders can maintain .32 on Nov. 16th capital structure improves dramatically with $15M injection🧐
1
Danger_Will_Robinson
$AEON see no reason for strength these last several days …. NO REASONS WHATSOEVER…. grab rug here …. PULL!
1

Advertisement|Remove ads.